BCM
BML Capital Management’s Oramed Pharmaceuticals ORMP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.94M | Buy |
3,083,253
+62,505
| +2% | +$141K | 5.25% | 6 |
|
|
2025
Q1 | $6.46M | Buy |
3,020,748
+376,841
| +14% | +$806K | 5.23% | 8 |
|
|
2024
Q4 | $6.4M | Buy |
2,643,907
+457,716
| +21% | +$1.11M | 3.97% | 9 |
|
|
2024
Q3 | $5.33M | Buy |
2,186,191
+837,153
| +62% | +$2.04M | 3.14% | 10 |
|
|
2024
Q2 | $3.47M | Buy |
1,349,038
+504,542
| +60% | +$1.3M | 2.47% | 9 |
|
|
2024
Q1 | $2.47M | Sell |
844,496
-417,063
| -33% | -$1.22M | 1.63% | 14 |
|
|
2023
Q4 | $2.91M | Buy |
1,261,559
+480,267
| +61% | +$1.11M | 2.21% | 11 |
|
|
2023
Q3 | $2.04M | Sell |
781,292
-68,708
| -8% | -$179K | 1.87% | 11 |
|
|
2023
Q2 | $3.04M | Sell |
850,000
-505,925
| -37% | -$1.81M | 2.74% | 12 |
|
|
2023
Q1 | $2.96M | Buy |
+1,355,925
| New | +$2.96M | 2.56% | 16 |
|